Back to the Media roomImmuPharma says US partner makes regulatory and operational progress ahead of phase III trial of lupus drug 20th November 2020Click hereShare this article Share on Facebook Share on Twitter
ImmuPharma says US partner makes regulatory and operational progress ahead of phase III trial of lupus drug 20th November 2020Click here
